FMO5 and metabolic dysfunction-associated steatotic liver disease: Notably, UA-induced hepatic injury is closely linked to oxidative stress: UA enhances ROS production via NADPH oxidase activation and mitochondrial dysfunction [39], while ROS impairs renal UA excretion to form a vicious cycle during MASLD progression [40].